1.The Study of Fetomaternal Transfusion in Korea.
Chul LEE ; Jun Hee SUL ; Kir Young KIM ; Duk Jin YUN
Journal of the Korean Pediatric Society 1980;23(12):983-990
Blood samples from mothers during labor and after delivery were tested for the occurrence of fetomaternal transfusing using Nierhaus acid elution technique. Fetomaternal transfusion had occured 1/2 of the mothers after delivery, 2/3 of the mothers during labor. The fetomateonal transfusions after delivery were most often less than 4.0?? and only few percent had fetomaternal transfusions more than 4.0??. Complicated pregnancy, duration of labor, induction of labor with oxytocics did not increased the incide- nce of fetomaternal transfusion. Manual removal of placenta increased the incidence of fetomaternal transfusion.
Female
;
Fetomaternal Transfusion*
;
Humans
;
Incidence
;
Korea*
;
Mothers
;
Oxytocics
;
Placenta
;
Pregnancy
3.Misoprostol in labour induction of term pregnancy: a meta-analysis.
Xiao-mao LI ; Jing WAN ; Cheng-fang XU ; Yu ZHANG ; Li FANG ; Zhong-jie SHI ; Kai LI
Chinese Medical Journal 2004;117(3):449-452
OBJECTIVETo evaluate the efficacy and safety of misoprostol in term labour induction.
DATA SOURCESData from published English and Chinese literatures about misoprostol in term labour induction were identified from Medline and CBMdisk (using the search terms "misoprostol" and "labour induction") before 2001; hand searches of reference lists of original studies and reviews (including meta-analyses) and contact with investigators in this field before 2001.
STUDY SELECTIONStudies were included if they had data on misoprostol and labour induction. Altogether 623 articles were found and 124 were admitted, including 19,287 cases.
DATA EXTRACTIONData were collected on efficacy and incidence of side-effects of misoprostol and oxytocin. Data were checked for consistency within the published articles and converted into a standard format for incorporation into a central database.
DATA SYNTHESISThe average successful induction rate, rates of caesarean section; incidence of tachysystole, hypertonus of uterus and precipitous labour, and rates of meconium stained amniotic fluid between the misoprostol and oxytocin groups were significantly different (P < 0.05). There were no significant differences between the two groups concerning the average interval from the administration of misoprostol and oxytocin to the onset of labour, duration of the total stage of labour, incidence rate of foetal distress, neonatal asphyxia (1-minute Apgar score < and= 7), postpartum haemorrhage or amount of blood loss in postpartum.
CONCLUSIONSMisoprostol is a superior agent over oxytocin on the induction of term labour, but its application might increase the risk of precipitous labour, abnormal uterine contractions or meconium stained amniotic fluid. Therefore, the dosages and regimens of the agent need further investigation.
Female ; Humans ; Labor, Induced ; methods ; Misoprostol ; adverse effects ; Oxytocics ; adverse effects ; Oxytocin ; Pregnancy ; Safety
4.The effect of oxytocin on fear responses: bidirectional regulation or methodological issues?
Lu-Yao WU ; Jia-Hui CHEN ; Bao-Jun LAI ; Jing-Chu HU
Acta Physiologica Sinica 2019;71(6):905-916
One of the core symptoms in anxiety disorders is dysregulated fear response. It is crucial for psychologists and neuroscientists to understand how fear responses are enhanced and inhibited. Although oxytocin (OXT) was initially conceived as a prosocial molecule and mammalian neuropeptide that enhances cooperation and trust, later studies showed that it produces modulatory influence on fear responses. Therefore, OXT is now regarded as a promising pharmacological agent to boost treatment response in anxiety disorders. However, the effect of OXT on fear responses have been somewhat complex, and there are some contradictions among animal experiments and human studies. In this article, we summarize recent studies that employed animal models, brain region-specific manipulations and preclinical studies to explore the role of OXT in the acquisition and processing of fear response. We also discuss the methodological differences among these studies and review the potential factors that may contribute to the complicated effect of OXT on fear response. This review will help to promote the potential clinical application of OXT.
Animals
;
Brain
;
drug effects
;
Fear
;
drug effects
;
Humans
;
Oxytocics
;
pharmacology
;
Oxytocin
;
pharmacology
5.Comparison of the effectiveness and pregnancy outcomes of labor induction with dinoprostone or single-balloon catheter in term nulliparous women with borderline oligohydramnios.
Yongqing ZHANG ; Luping CHEN ; Guohui YAN ; Menglin ZHOU ; Zhengyun CHEN ; Zhaoxia LIANG ; Danqing CHEN
Chinese Medical Journal 2022;135(6):681-690
BACKGROUNDS:
At present, there is no consensus on the induction methods in term pregnancy with borderline oligohydramnios. This study aimed to compare the effectiveness and pregnancy outcomes of labor induction with dinoprostone or single-balloon catheter (SBC) in term nulliparous women with borderline oligohydramnios.
METHODS:
We conducted a retrospective cohort study from January 2016 to November 2018. During the study period, a total of 244 cases were enrolled. Of these, 103 cases were selected for induction using dinoprostone and 141 cases were selected for induction with SBC. The pregnancy outcomes between the two groups were compared. Primary outcomes were successful vaginal delivery rates. Secondary outcomes were maternal and neonatal adverse events. Multivariate logistic regression was used to assess the risk factors for vaginal delivery failure in the two groups.
RESULTS:
The successful vaginal delivery rates were similar between the dinoprostone group and the SBC group (64.1% [66/103] vs. 59.6%, [84/141] P = 0.475), even after adjustment for potential confounding factors (adjusted odds ratio [aOR]: 1.07, 95% confidence interval [CI]: 0.57-2.00, P = 0.835). The incidence of intra-amniotic infection was lower in the dinoprostone group than in the SBC group (1.9% [2/103] vs. 7.8%, [11/141] P < 0.001), but the presence of non-reassuring fetal heart rate was higher in the dinoprostone group than in the SBC group (12.6% [13/103] vs. 0.7%, [1/141] P < 0.001). Multivariate logistic regression showed that nuchal cord was a risk factor for vaginal delivery failure after induction with dinoprostone (aOR: 6.71, 95% CI: 1.96-22.95). There were three factors related to vaginal delivery failure after induction with SBC, namely gestational age (aOR: 1.51, 95% CI: 1.07-2.14), body mass index (BMI) >30 kg/m2 (aOR: 2.98, 95% CI: 1.10-8.02), and fetal weight >3500 g (aOR: 2.49, 95% CI: 1.12-5.50).
CONCLUSIONS
Term nulliparous women with borderline oligohydramnios have similar successful vaginal delivery rates after induction with dinoprostone or SBC, with their advantages and disadvantages. In women with nuchal cord, the risk of vaginal delivery failure is increased if dinoprostone is used in the induction of labor. BMI >30 kg/m2, large gestational age, and estimated fetal weight >3500 g are risk factors for vaginal delivery failure after induction with SBC.
Administration, Intravaginal
;
Catheters
;
Dinoprostone/therapeutic use*
;
Female
;
Fetal Weight
;
Humans
;
Infant, Newborn
;
Labor, Induced/methods*
;
Nuchal Cord
;
Oligohydramnios
;
Oxytocics
;
Pregnancy
;
Pregnancy Outcome
;
Retrospective Studies
6.Postcoital administration of asoprisnil inhibited embryo implantation and disturbed ultrastructure of endometrium in implantation window in mice.
Xiao-li WU ; Zhi-hong YU ; Jun QIU ; Yi-hong YANG ; Xiao-li SHEN ; Ping SU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2013;33(2):277-283
Asoprisnil, a member of the selective progesterone receptor modulators, exerts high progesterone receptor selectivity, endometrial targeted advantages and significant anti-implantation effect in rats. The purpose of this study was to confirm the anti-implantation effect of asoprisil, investigate the ultrastructural changes of the peri-implantation endometrium in mice and explore the effect of asoprisnil on endometrial receptivity and its targeted contraceptive proficiency. Post-coitus mice were administered with different dosages (0.2, 0.1, 0.05 mg·g(-1)·day(-1)) of asoprisnil from day 1 of pregnancy to day 3. Then 3 animals in each group were killed on day 5 of pregnancy, and uteri were collected to examine the ultrastructural changes of endometria under a transmission electron microscope (TEM). A total of 80 animals were sacrificed on day 8 of pregnancy, and the uterine horns were examined for the presence or absence of nidation sites and the number of implantation embryos. The results showed that the implantation rate and the average number of implantation embryos in asoprisnil groups were statistically significantly decreased as compared with the vehicle control group (P<0.05). The TEM results revealed that, in vehicle control group, the tight junction between the luminal epithelia cells was short and straight, the gap was wide; the luminal epithelia cells were covered with plenty of short, clavate and neatly arranged microvilli; the endometril stromal cells were large with plenty of cytoplasm, and showed significant decidual change; there was more than one nucleus in stromal cells, and the karyotheca was integrity. In low dosage and high dosage asoprisnil groups, the tight junction was longer and more curve than in the vehicle control group; microvilli were uneven and asymmetrically distributed in luminal epithelia; the stromal cells were small and the decidual change was not significant; there were karyopyknosis and karyolysis in stromal cells; there were abnormal thick-wall vessels in the endometrium. It was suggested that asoprisnil changed the ultrastructure of the endometrium in implantation window, disturbed the endometrial receptivity and finally resulted in embryo implantation failure.
Animals
;
Contraception, Postcoital
;
methods
;
Embryo Implantation, Delayed
;
drug effects
;
physiology
;
Endometrium
;
drug effects
;
physiology
;
ultrastructure
;
Estrenes
;
administration & dosage
;
Female
;
Mice
;
Oximes
;
administration & dosage
;
Oxytocics
;
administration & dosage
;
Pregnancy
;
Pregnancy, Animal
;
Treatment Outcome
7.Clinical value of adjuvant therapy with estrogen for postpartum hemorrhage.
Mo ZHOU ; Chun-yan YANG ; Yang ZHAO ; Ping LI
Journal of Southern Medical University 2006;26(6):865-866
OBJECTIVETo investigate the clinical efficacy of estrogen in management of postpartum hemorrhage due to uterine atony.
METHODSTotalling 112 puerperants with postpartum hemorrhage due to uterine atony were randomly assigned into 2 groups and received routine managements for uterine atony such as uterine massage and uterotonics administration. The puerperants in one group (n=52) was treated with 4 mg estradiol benzoate injected intramuscularly, and the amount of blood loss 2 h after delivery and between 2 and 24 h after delivery was recorded.
RESULTSThere were significant differences in vaginal blood loss at 2 h after delivery between the 2 groups (P<0.05). The puerperants with estrodiol benzoate treatment had blood loss of 589.6-/+226.4 ml at 2 h and 110.8-/+76.2 ml within 2-24 h after delivery, which were both less than those in the control group (864.5-/+359.5 ml and 161.5-/+98.3 ml, respectively). Postpartum hysterectomy was performed in 3 cases of the control group while none in estradiol benzoate-treated group. In the mothers and neonates, no major adverse effects were observed.
CONCLUSIONEstrogen shows cooperative efficacy with uterotonics in stimulating uterine contraction for managements of postpartum hemorrhage due to uterine atony, and can be of value in clinical application.
Adult ; Delivery, Obstetric ; adverse effects ; Drug Therapy, Combination ; Estradiol ; analogs & derivatives ; therapeutic use ; Female ; Humans ; Oxytocics ; therapeutic use ; Postpartum Hemorrhage ; drug therapy ; etiology ; Pregnancy ; Treatment Outcome ; Uterine Inertia ; drug therapy
8.Comparative Analysis of Delivery Management in Various Medical Facilities.
Jung Han PARK ; Young Sook YOU ; Jang Rak KIM
Korean Journal of Preventive Medicine 1989;22(4):555-577
This study was conducted to compare the delivery management including laboratory tests, medication and surgical procedures for the delivery in various medical facilities. Two university hospitals, two general hospitals, three hospitals, two private obstetric clinics, and two midwifery clinics in a large city were selected as they permitted the investigators to abstract the required data from the medical and accounting records. The total number of deliveries occurred at these 11 facilities between 15 January and 15 February, 1989 was 789 among which 606(76.8%) were vaginal deliveries and 183(23.3%) were C-sections. For the normal vaginal deliveries, CBC, Hb/Hct level, blood typing, VDRL, hepatitis B antigen and antibody, and urinalysis were routinely done except the private clinics and midwifery clinics which did not test for hepatitis B and Hb/Hct level at all. In one university hospital ultrasonography was performed in 71.4% of the mothers and in one general hospital liver function test was done in 76.7% of the mothers. For the C-section, chest X-ray, bleeding / clotting time and liver function test were routinely done in addition to the routine tests for the normal vaginal deliveries. Episiotomy was performed in 97.2% of the vaginal deliveries. The type and duration of fluid infused and antibiotics administered showed a wide variation among the medical facilities. In one university hospital antibiotics was not administered after C-section at all while in the general hospitals and hospitals one or two antibiotics were administered for one week on the average. In one private clinic one pint of whole blood was transfused routinely. A wide variation was observed among the medical facilities in the use of vitamin, hemostatics, oxytocics, antipyreptics, analgesics, anti-inflammatory agents, sedatives, digestives, stool softeners, antihistamines, and diuretics. Mean hospital day for the norma vaginal deliveries of primipara was 2.6 days with little variation except one hospital with 3.5 days. Mean hospital day for the C-section of primipara was 7.5 days and that of multipara was 7.6 days and it ranged between 6.5 days and 9.4 days. Average hospital fee for a normal vaginal delivery without the medical insurance coverage was 182,100 Won for the primipara and 167,300 Won for the multipara. In case of the primipara covered by the medical insurance a mother paid 82,400 Won and a multiparous mother paid 75,600 Won. Average hospital fee for a C-section without the medical insurance was 946,500 Won for the primipara and 753,800 Won for the multipara. In case of the primipara covered by the medical insurance a mother paid 256,200 Won and a multiparous mother paid 253,700 Won. Average hospital fee for a normal vaginal delivery in the university hospitals showed a remarkable difference, 268,000 Won vs 350,000 Won, as well as for the C-section. A wide variation in the laboratory tests performed for a normal vaginal delivery and a C-section as well as in the medication and hospital days brought about a big difference in the hospital fee and some hospitals were practicing the case payment system. Thus, standardization of the medical care to a certain level is warranted for the provision of adequate medical care for delivery.
Anti-Bacterial Agents
;
Anti-Inflammatory Agents, Non-Steroidal
;
Blood Grouping and Crossmatching
;
Diuretics
;
Episiotomy
;
Fees and Charges
;
Female
;
Hemorrhage
;
Hemostatics
;
Hepatitis B
;
Histamine Antagonists
;
Hospitals, General
;
Hospitals, University
;
Humans
;
Hypnotics and Sedatives
;
Insurance
;
Insurance Coverage
;
Liver Function Tests
;
Midwifery
;
Mothers
;
Oxytocics
;
Research Personnel
;
Thorax
;
Ultrasonography
;
Urinalysis
;
Vitamins
9.Coronary Vasospastic Angina: Assessment by Multidetector CT Coronary Angiography.
Koung Mi KANG ; Sang Il CHOI ; Eun Ju CHUN ; Jeong A KIM ; Tae Jin YOUN ; Dong Ju CHOI
Korean Journal of Radiology 2012;13(1):27-33
OBJECTIVE: We aimed to describe the imaging findings of multidetector CT coronary angiography (MDCTA) in cases of vasospastic angina (VA) and to determine the accuracy of MDCTA in the identification of VA as compared with invasive coronary angiography with an ergonovine provocation test (CAG with an EG test). MATERIALS AND METHODS: Fifty-three patients with clinically suspected VA were enrolled in this study. Two radiologists analyzed the stenosis degree, presence or absence of plaque, plaque composition, and a remodeling index of the related-segment in CAG with an EG test, which were used as a gold standard. We evaluated the diagnostic performances of MDCTA by comparing the MDCTA findings with those of CAG with an EG test. RESULTS: Among the 25 patients with positive CAG with an EG test, all 12 patients with significant stenosis showed no definite plaque with the negative arterial remodeling. Of the six patients with insignificant stenosis, three (50%) had non-calcified plaque (NCP), two (33%) had mixed plaque, and one (17%) had calcified plaque. When the criteria for significant stenosis with negative remodeling but no definite evidence of plaque as a characteristic finding of MDCTA were used, results showed sensitivities, specificities, positive predictive values (PPV), and negative predictive values (NPV) of 48%, 100%, 100%, and 68%, respectively. CONCLUSION: Significant stenosis with negative remodeling, but no definite evidence of plaque, is the characteristic finding on MDCTA of VA. Cardiac MDCTA shows good diagnostic performance with high specificity and PPV as compared with CAG with an EG test.
Angina Pectoris/*radiography
;
Chi-Square Distribution
;
Comorbidity
;
Contrast Media/diagnostic use
;
Coronary Angiography/*methods
;
Electrocardiography
;
Ergonovine/diagnostic use
;
Female
;
Humans
;
Iopamidol/analogs & derivatives/diagnostic use
;
Male
;
Middle Aged
;
Oxytocics/diagnostic use
;
Predictive Value of Tests
;
Radiographic Image Interpretation, Computer-Assisted
;
Retrospective Studies
;
Sensitivity and Specificity
;
Tomography, X-Ray Computed/*methods